Jack is the CSIRO representative on the Investment Committee.
Jack is the Director, Science Impact and Policy at CSIRO. In this role, he supports the CSIRO Chief Executive and the Executive Team in relation to policy aspects of CSIRO’s science and analysis of CSIRO’s science performance. This includes ethical aspects of CSIRO's research. In 2019, CSIRO adopted a new Science & Delivery Policy, together with associated changes in the Code of Conduct, to adopt and implement the 2018 Australian Code for Responsible Research.
Jack’s research career during the period of 1979 - 2000 included postdoctoral studies in metastatic cancer spread, development of novel implantable biomaterials and the management of projects to develop gene therapy for prostate cancer. Since 2000, Jack has held corporate roles that involved managing corporate governance for science and commercial activities at CSIRO.